Matinas BioPharma Announces Complete Clinical Response In Three Patients With Serious Invasive Fusarium Infection Following Treatment With MAT2203
Matinas BioPharma 宣布三名在接受 MAT2203 治疗后患有严重侵入性镰刀菌感染的患者有完整的临床反应
Matinas BioPharma Announces Complete Clinical Response In Three Patients With Serious Invasive Fusarium Infection Following Treatment With MAT2203
Matinas BioPharma 宣布三名在接受 MAT2203 治疗后患有严重侵入性镰刀菌感染的患者有完整的临床反应
使用浏览器的分享功能,分享给你的好友吧